1.
Vedamurthy M, Humbert P. A randomized, open label, comparative, five-arm, controlled study evaluating the benefit and tolerability of oral superoxide dismutase combined with gliadin as add-on neutraceutical therapy with standard therapy in Indian patients with melasma. Int J Res Dermatol [Internet]. 2018 Oct. 25 [cited 2025 Feb. 10];4(4):471-8. Available from: https://www.ijord.com/index.php/ijord/article/view/211